Tsh Biopharmoration (Taiwan) Today
| 8432 Stock | TWD 61.20 0.20 0.33% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Tsh Biopharmoration is selling for under 61.20 as of the 10th of January 2025; that is 0.33 percent increase since the beginning of the trading day. The stock's lowest day price was 60.1. Tsh Biopharmoration has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 11th of December 2024 and ending today, the 10th of January 2025. Click here to learn more.
TSH Biopharm Corporation Limited develops, manufactures, and markets drugs for various chronic diseases in Taiwan and China. TSH Biopharm Corporation Limited is a subsidiary of TTY Biopharm Company Limited. TSH BIOPHARM is traded on Taiwan OTC Exchange in Taiwan. The company has 38.4 M outstanding shares. More on tsh biopharmoration
Moving against Tsh Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Tsh Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Tsh Biopharmoration's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Tsh Biopharmoration or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Drug Manufacturers - Major, Healthcare (View all Sectors) |
tsh biopharmoration (8432) is traded on Taiwan OTC Exchange in Taiwan and employs 80 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.78 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Tsh Biopharmoration's market, we take the total number of its shares issued and multiply it by Tsh Biopharmoration's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. tsh biopharmoration operates under Healthcare sector and is part of Drug Manufacturers - Major industry. The entity has 38.4 M outstanding shares.
tsh biopharmoration has accumulated about 708.28 M in cash with 68.71 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 18.36.
Check Tsh Biopharmoration Probability Of Bankruptcy
Ownership Allocationtsh biopharmoration shows a total of 38.4 Million outstanding shares. tsh biopharmoration has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 64.94 % of Tsh Biopharmoration outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Tsh Ownership Details
tsh biopharmoration Risk Profiles
Although Tsh Biopharmoration's alpha and beta are two of the key measurements used to evaluate Tsh Biopharmoration's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.06 | |||
| Standard Deviation | 1.52 | |||
| Variance | 2.3 | |||
| Risk Adjusted Performance | (0.02) |
Tsh Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Tsh Biopharmoration without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Pair Correlation Now
Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments |
| All Next | Launch Module |
Tsh Biopharmoration Corporate Management
Elected by the shareholders, the Tsh Biopharmoration's board of directors comprises two types of representatives: Tsh Biopharmoration inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Tsh. The board's role is to monitor Tsh Biopharmoration's management team and ensure that shareholders' interests are well served. Tsh Biopharmoration's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Tsh Biopharmoration's outside directors are responsible for providing unbiased perspectives on the board's policies.
| ChenJu Kan | Mang Admin | Profile | |
| JianRong Huang | Sales Director | Profile | |
| Xinyang Liu | Vice Admin | Profile | |
| HsinYoung Liu | Company Sec | Profile | |
| SzeYuan Yang | G Mang | Profile |
Additional Tools for Tsh Stock Analysis
When running Tsh Biopharmoration's price analysis, check to measure Tsh Biopharmoration's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tsh Biopharmoration is operating at the current time. Most of Tsh Biopharmoration's value examination focuses on studying past and present price action to predict the probability of Tsh Biopharmoration's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tsh Biopharmoration's price. Additionally, you may evaluate how the addition of Tsh Biopharmoration to your portfolios can decrease your overall portfolio volatility.